Home
Online Advanced Release
Current Issue
Online-only Articles
Back Issues
Product News
About the Journal
Advertising Info
Contact Us
Article Reprints
Article Submission
Buy a Book
Terms and Conditions
Careers at SLACK Inc.
ISIE
 
  e-contents - sign up today
  Subscribe to this Journal
Get daily Ophthalmic news at the OSN SuperSite

Curbside Consultation in Neuro-Ophthalmology

Clinical Science

Long-Term Ophthalmological Follow-up of Children With Parinaud Syndrome

Ophthalmic Surgery, Lasers and Imaging   Vol. 41   No. 4   July/August 2010
See the Full text
Nitza Goldenberg-Cohen, MD; Jordana Haber, MD; Yonina Ron, MD; Liora Kornreich, MD; Helen Toledano, MD; Moshe Snir, MD; Ian J. Cohen, MD and Shalom Michowiz, MD

Share/Save/Bookmark

 

BACKGROUND AND OBJECTIVE

To assess the long-term ophthalmological outcome of Parinaud syndrome.

PATIENTS AND METHODS

The files of 6 children with tumor-related Parinaud syndrome diagnosed and observed from 2000 to 2007 were reviewed. All had papilledema indicating increased intracranial pressure.

RESULTS

Mean presentation-to-diagnosis delay was 3.6 weeks. Treatment consisted of surgical shunting and complete or partial resection with adjuvant chemotherapy (n = 4) and radiation (n = 3). Visual acuity remained stable or improved in 8 of 9 eyes with 20/30 visual acuity at diagnosis; improved bilaterally in 1 patient from 20/100 to 20/25; and deteriorated bilaterally in 1 patient from 20/30 and 20/200 to counting fingers and hand motions, respectively. The most improvement was achieved within 4 months. Findings at follow-up (mean: 4.2 years) included up gaze limitation (minimal in 2 patients), abnormal convergence, convergence retraction nystagmus, and light-near dissociation. One child had bilateral optic atrophy.

CONCLUSION

Children with tumor-related Parinaud syndrome tend to have subtle but measurable residual ophthalmological findings years after diagnosis and treatment.

[Ophthalmic Surg Lasers Imaging 2010;41:467-471.]

AUTHORS

From the Department of Ophthalmology (NG-C, YR, MS), Rabin Medical Center, Beilinson Campus, Petach Tikva; the Pediatric Ophthalmology Unit (NG-C, YR, MS) and the Departments of Pediatric Radiology (LK), Oncology (HT, IJC), and Neurosurgery (SM), Schneider Children’s Medical Center of Israel, Petach Tikva; and the Sackler Faculty of Medicine (NG-C, JH, LK, HT, MS, IJC, SM), Tel Aviv University, Tel Aviv, Israel.

Originally submitted November 1, 2008. Accepted for publication January 9, 2010. Posted online April 29, 2010.

The authors have no financial or proprietary interest in the materials presented herein.

The authors thank Gloria Ginzach for her editorial assistance.

Address correspondence to Nitza Goldenberg-Cohen, MD, Pediatric Ophthalmology Unit, Schneider Children’s Medical Center of Israel, Petach Tikva 49202, Israel.

doi: 10.3928/15428877-20100426-02

See the Full text